276 related articles for article (PubMed ID: 30635931)
21. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y
Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer.
Zuo Y; Li Y; Zhou Z; Ma M; Fu K
Biomed Pharmacother; 2017 Nov; 95():922-928. PubMed ID: 28915533
[TBL] [Abstract][Full Text] [Related]
23. YY1-regulated LINC00152 promotes triple negative breast cancer progression by affecting on stability of PTEN protein.
Shen X; Zhong J; Yu P; Zhao Q; Huang T
Biochem Biophys Res Commun; 2019 Feb; 509(2):448-454. PubMed ID: 30594392
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancer.
Zheng S; Yang L; Zou Y; Liang JY; Liu P; Gao G; Yang A; Tang H; Xie X
J Hematol Oncol; 2020 Mar; 13(1):17. PubMed ID: 32138762
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA HIF1A-AS2 modulates the proliferation, migration, and phenotypic switch of aortic smooth muscle cells in aortic dissection via sponging microRNA-33b.
Zhang K; Qi Y; Wang M; Chen Q
Bioengineered; 2022 Mar; 13(3):6383-6395. PubMed ID: 35212609
[TBL] [Abstract][Full Text] [Related]
26. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA GAS6-AS2 sponges microRNA-493, thereby enhancing the malignant characteristics of breast cancer cells via upregulation of FUT4.
Li W; Jin X; Zhao Y; Dai J; Cai Y
Pathol Res Pract; 2020 Feb; 216(2):152772. PubMed ID: 31839366
[TBL] [Abstract][Full Text] [Related]
28. Subcellular expression of MTA1, HIF1A and p53 in primary tumor predicts aggressive triple negative breast cancers: a meta-analysis based study.
Sharaf SS; Jaganath Krishna KM; Lekshmi A; Sujathan
J Mol Histol; 2024 Jun; 55(3):303-315. PubMed ID: 38613589
[TBL] [Abstract][Full Text] [Related]
29. LncRNA HIF1A-AS2 modulated by HPV16 E6 regulates apoptosis of cervical cancer cells via P53/caspase9/caspase3 axis.
Guan HM; Li WQ; Liu J; Zhou JY
Cell Signal; 2022 Sep; 97():110390. PubMed ID: 35728704
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of HIF1A-AS2 suppresses TRIM44 to protect cardiomyocytes against hypoxia-induced injury.
Luo F; Wu Y; Zhu L; Zhang J; Liu Y; Jia W
Cell Biol Int; 2020 Jul; 44(7):1523-1534. PubMed ID: 32222118
[TBL] [Abstract][Full Text] [Related]
31. LncRNA MIR503HG inhibits cell migration and invasion via miR-103/OLFM4 axis in triple negative breast cancer.
Fu J; Dong G; Shi H; Zhang J; Ning Z; Bao X; Liu C; Hu J; Liu M; Xiong B
J Cell Mol Med; 2019 Jul; 23(7):4738-4745. PubMed ID: 31062436
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA HIF1A-AS2 promotes carcinogenesis by enhancing Gli1-mediated HIF1α expression in clear cell renal cell carcinoma.
Li X; Wu Y; Xiao Z; Liu Y; Wang C; Zhou L; Yang X
Pathol Res Pract; 2024 Jan; 253():154984. PubMed ID: 38064865
[TBL] [Abstract][Full Text] [Related]
33. LncRNA HIF1A-AS2: a potential biomarker for early diagnosis of acute myocardial infarction and predictor of left ventricular dysfunction.
Tayae E; Amr E; Zaki A; Elkaffash D
BMC Cardiovasc Disord; 2023 Mar; 23(1):135. PubMed ID: 36918770
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA HIF1A-As2 and MYC form a double-positive feedback loop to promote cell proliferation and metastasis in KRAS-driven non-small cell lung cancer.
Yang K; Zhang W; Zhong L; Xiao Y; Sahoo S; Fassan M; Zeng K; Magee P; Garofalo M; Shi L
Cell Death Differ; 2023 Jun; 30(6):1533-1549. PubMed ID: 37041291
[TBL] [Abstract][Full Text] [Related]
35. circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer.
Tang H; Huang X; Wang J; Yang L; Kong Y; Gao G; Zhang L; Chen ZS; Xie X
Mol Cancer; 2019 Feb; 18(1):23. PubMed ID: 30744636
[TBL] [Abstract][Full Text] [Related]
36. LncRNA WT1-AS Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Downregulating Transforming Growth Factor β1.
Wang J; Xi C; Yang X; Lu X; Yu K; Zhang Y; Gao R
Cancer Biother Radiopharm; 2019 Dec; 34(10):671-675. PubMed ID: 31621381
[No Abstract] [Full Text] [Related]
37. Long non-coding RNA (LncRNA) RMST in triple-negative breast cancer (TNBC): Expression analysis and biological roles research.
Wang L; Liu D; Wu X; Zeng Y; Li L; Hou Y; Li W; Liu Z
J Cell Physiol; 2018 Oct; 233(10):6603-6612. PubMed ID: 29215701
[TBL] [Abstract][Full Text] [Related]
38. LncRNA TCONS_l2_00002973 correlates with less advanced tumor stage and favorable survival, and also inhibits cancer cells proliferation while enhancing apoptosis in triple-negative breast cancer.
Yan J; Wang R; Wu Z
J BUON; 2019; 24(2):535-542. PubMed ID: 31128002
[TBL] [Abstract][Full Text] [Related]
39. Diaphanous-related formin-3 overexpression inhibits the migration and invasion of triple-negative breast cancer by inhibiting RhoA-GTP expression.
Jiang J
Biomed Pharmacother; 2017 Oct; 94():439-445. PubMed ID: 28779705
[TBL] [Abstract][Full Text] [Related]
40. lncRNA LINC000466 Predicts the Prognosis and Promotes the Progression of Triple-negative Breast Cancer via Modulating miR-539-5p.
Liu J; Yu H; Cui H; Wei F; Yan T; Li T; Liu Y; Chu J
Clin Breast Cancer; 2022 Jun; 22(4):374-380. PubMed ID: 35216934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
